MENU
ELVN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Enliven Therapeutics (ELVN) Ownership - Who owns Enliven Therapeutics?
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics... Show more
Profile
Industry
N/A
Address
6200 Lookout Road
Phone
+1 720 647-8519
Employees
46
Web
https://www.enliventherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.22B
P/E Ratio
N/A
Total Cash
490.5M
Projected Growth
N/A
Total Debt
580K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
8.28
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ELVN
Capitalization
1.23B
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
491M
Total Cash/Share
8.28
Total Debt
580K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
488M
P/B Ratio
2.51
Cash Flow
N/A
Earnings
-1.99
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
59K
Current Ratio
32.58
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-113.93M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-24.12
Shares Held By Institutions
1.44B
Shares Outstanding - Current
59.2M
Total Liabilities
15.4M
Total Volume MTD
N/A
Value
1
Gain YTD
-9.511
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ELVN showed earnings on August 13, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
6200 Lookout Road
Phone
+1 720 647-8519
Employees
46
Web
https://www.enliventherapeutics.com